Antibody Detection – AT1R/ETAR

https://cytomed.ae/products/antibody-detection-at1retar/

Non-HLA Antibodies and AMR?

Anti-AT1R and anti-ETAR antibodies may have an associated risk for antibody mediated rejection.

One Lambda now has a solution to detect biomarker antibodies that form against angiotensin II type 1 receptors (AT1R) and endothelin receptors type A (ETAR). Our anti-AT1R and anti-ETAR antibody assays offer a new approach to transplant diagnostic testing at a non-HLA level.

Because successful transplants can require more than just classic HLA Testing.


Solutions :


Angiotensin II type 1 receptor (AT1R)

By detecting biomarker antibodies that form against angiotensin II type 1 receptor (AT1R), this assay offers a new approach to transplant diagnostic testing at a non-HLA level. AT1R is found in most major organs, suggesting the importance of anti-AT1R antibodies as a possible biomarker for solid organ transplants and Antibody Mediated Rejection.

Exclusive to One Lambda, the AT1R assay addresses a new direction for suggested transplant monitoring.

 

Features & Benefits

  • Recognizes anti-AT1R Antibodies
  • Straight forward ELISA based procedure
  • Built in standards and controls to validate result reliability
  • Stand-alone result interpretation with the Multiskan FC

Endothelin receptor type A (ETAR)

 

By detecting biomarker antibodies that form against endothelin receptor type A (anti-ETAR), this assay offers a new approach to transplant research at a non-HLA level.

Exclusive to One Lambda, the ETAR assay addresses a new direction for suggested transplant monitoring.


 

Product Specifications

Description Parametres
Product Division Laboratory Division
Brand Lab Division Brands

Send Enquiry

[mathcaptcha mathcaptcha-45 id:captchaI]

Medical Division

Laboratory Division

Industry Business Unit